Praxis Investment Management Inc. Has $1.39 Million Position in GE HealthCare Technologies Inc. $GEHC

Praxis Investment Management Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 86.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,516 shares of the company’s stock after buying an additional 8,606 shares during the quarter. Praxis Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $1,391,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Dodge & Cox grew its holdings in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares in the last quarter. Norges Bank acquired a new stake in GE HealthCare Technologies during the second quarter valued at $468,120,000. Holocene Advisors LP grew its stake in GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies in the 2nd quarter worth about $80,755,000. Finally, Balyasny Asset Management L.P. acquired a new position in GE HealthCare Technologies in the 2nd quarter worth about $58,388,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.4%

Shares of GEHC stock opened at $83.96 on Monday. The firm has a market capitalization of $38.25 billion, a P/E ratio of 17.35, a price-to-earnings-growth ratio of 3.51 and a beta of 1.09. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The firm’s fifty day simple moving average is $76.82 and its 200 day simple moving average is $75.02. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. During the same period last year, the business posted $1.14 EPS. The business’s quarterly revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Ratings Changes

Several equities research analysts recently commented on GEHC shares. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 1st. Barclays began coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Morgan Stanley increased their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Finally, Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $87.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.